HEALTHYBYTESTM
THE ONLINE HEALTH AND WELLNESS NEWSLETTER


A Quarterly Publication of:
TheraCompTM                
April/May/June 2001
TheraComp is the occupational rehabilitation division of Strength Training
Rehabilitation

Health News

Plant Hormones May Help Treat Cancer
By Patricia Reaney
Reuters

LONDON (May 23) - A hormone used by plants to control their growth is being harnessed by British researchers to develop new targeted treatments for cancer, researchers said on Wednesday.

Plants need the hormone, called indole acetic acid (IAA), to bend shoots towards sunlight to help cuttings grow roots. Scientists at the Cancer Research Campaign, a leading scientific charity, are using fragments of IAA
to kill cancer cells.

The hormone, which is produced by most plants, is harmless to humans. But, in early laboratory studies when scientists used bits of it and coupled them with an enzyme, it produced toxic by-products that destroyed cancerous tumors
without harming healthy cells.
Source: AOL News
***************************************************************************

Home-grown breasts could replace implants   
LONDON (Reuters) - Breast implants for reconstructive surgery after a mastectomy or for breast enhancement may not be necessary in the future, a science magazine reported Wednesday.

Tissue engineers in Australia have developed a technique that could allow women to grow their own new breast tissue.

The method developed by Kevin Cronin and scientists at the Bernard O'Brien Institute of Microsurgery in Melbourne has been successfully tested on rats, mice and rabbits.

"Rather than growing the patient's tissue in the lab and then transplanting it back into the body, as has been done in animal studies in the past, Cronin grows the tissue on site," New Scientist magazine said.
Source: AOL News
**************************************************************************
Botox could help back pain
May 22, 2001 Posted: 2:47 PM EDT (1847 GMT)
(CNN) -- A drug derived from a type of bacteria that causes food poisoning may provide relief for those who suffer chronic low back-pain, according to a new study. Researchers at the Walter Reed Army Medical Center found that
people who received injections of botulinum toxin A, or Botox, experienced a reduction in back pain for as long as three to four months.

All the people who took part in the research had experienced lower back pain for an average of six years, and all of them were taking various medications to relieve the pain, inflammation and muscle spasms associated with their
condition. They stayed on the medication throughout the experiment. Fifteen patients received botulinum toxin A, or Botox, injections, and 16 received a placebo of saline solution. After three weeks, 11 of the 15 Botox patients
said their pain diminished by at least half. Four of the 16 who received saline said their pain had been reduced by at least 50 percent.

After two months, nine of the 15 Botox recipients said their pain had been reduced by more than 50 percent. Only two patients on the saline solution reported a similar reduction.
Source: CNN
***************************************************************************
Study: Hormones Reduce Cancer Risk
By PAUL RECER
.c The Associated Press

WASHINGTON (May 15) - Hormone replacement therapy after a diagnosis of breast cancer does not increase the risk of recurrence of the disease and may even lower chances that the cancer will return, according to a new study.

The therapy, in which post-menopausal women take pills to replace female hormones that diminish with age, generally has been avoided by women with breast cancer because it was known that estrogen was linked to the growth of
some tumors.

But Dr. Ellen O'Meara, a University of Washington cancer researcher, said her new study in the Journal of the National Cancer Institute suggests that breast cancer patients should not fear hormone replacement therapy, or HRT.

``The data are reassuring for women who take HRT after a breast cancer diagnosis,'' O'Meara said Tuesday. ``HRT need not be ruled out automatically.''
Source: AOL News
***************************************************************************
Interesting Statistics
Statistics show disparity between the health of black and white Americans. Life Expectancy: A white baby born in 1996 can expect to live for 76.8 years while a black baby will live 70.0 years. Cancer: The death rate for cancer
among black men is 50% higher than for white men. Stroke: Blacks are nearly twice as likely to die of strokes than white Americans.
Source: Dept. of Health and Human Services

Average cost of a low back injury requiring surgery is $40, 000, $29,000 for carpal tunnel surgery. For every $$ a company spends in  these direct costs they will spend another another 3-5 times on indirect costs such as
productivity loss, overtime, rehiring and retraining.
*************************************************************************
TheraCompTM and Strength Training RehabTM Announcements
The management and staff at TherComp and Strength Training Rehabilitation would like to welcome Chester Petrosky and Bill Klein to our management and marketing teams. Each of these gentlemen bring loads of experience in their
respective fields. We are very pleased to have them on board. Chester our Business Manager can be reached at (602) 547-1836 and Bill can be reached at (602) 821-6892.

Also, we wanted to take this opportunity to remind each of our referral sources that our 24/7 Injury, Referral and Care Coordination Hotline is available and fully functional. The number is (602) 547-5912. Call this number for any of your referral, patient care or communicative needs. Erin, our very capable Care Coordinator, will assist and expedite your patient referrals and scheduling to any of our PT, Hand and Industrial clinics across Arizona.

Outcomes:
Since November 2000 we have received 19 referrals into our industrial work-conditioning program. At the time of referral, all patients were either not working or on modified/light/transitional work status (for an average of
4 months). Recent outcomes show that of these 19 patients, 10 have returned to full duty work unrestricted, 2 returned to their pre-injury job with some modifications and accommodations, 1 has been recently discharged with status
unknown at this time, 5 remain in the program and 1 was discharged as no further authorization was provided by carrier. Payors of 16 of these referrals were industrial carriers and 3 were from a private disability carrier. The average duration of each program was 4.7 weeks and averaged a total cost of $1900.00 per case.